bluebird bio (BLUE) Posts Wider-than-Expected Q3 Loss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
bluebird bio Reports Third Quarter 2015 Financial Results and Recent Operational Progress
November 4, 2015 4:09 PM EST-- Six abstracts accepted for presentation at American Society of Hematology (ASH) Annual Meeting --
-- Increased enrollment target for HGB-206 study of LentiGlobin® in severe sickle cell disease (SCD) from eight patients to 20 patients -
-- Published a paper on megaTAL genome editing platform in Science Translational Medicine with collaborators at Seattle Childrens Research Institute --
-- Ended quarter with $901.7 million in cash, cash equivalents, and marketable securities --
-- Company will discuss ASH... More
